Holen Sie sich die Stockscreener-App
0.2924
0.81%
-0.0024
Vorhandelsmarkt:
.30
0.0076
+2.60%
Schlusskurs vom Vortag:
$0.2948
Offen:
$0.3076
24-Stunden-Volumen:
589.40K
Relative Volume:
0.24
Marktkapitalisierung:
$34.92M
Einnahmen:
$436.97M
Nettoeinkommen (Verlust:
$-35.62M
KGV:
-0.9802
EPS:
-0.2983
Netto-Cashflow:
$-10.71M
1W Leistung:
+6.13%
1M Leistung:
+16.87%
6M Leistung:
-45.38%
1J Leistung:
-80.64%
1-Tages-Spanne:
$0.287
$0.317
1-Wochen-Bereich:
$0.2631
$0.3387
52-Wochen-Spanne:
$0.22
$2.10
Accuray Inc Stock (ARAY) Company Profile
Firmenname
Accuray Inc
Sektor
Branche
Telefon
608-824-2800
Adresse
1240 DEMING WAY, MADISON, CA
Compare ARAY vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
0.2924 | 35.21M | 436.97M | -35.62M | -10.71M | -0.2983 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-13 | Eingeleitet | ROTH MKM | Buy |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-12-22 | Eingeleitet | Loop Capital | Buy |
| 2020-01-21 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-11-01 | Hochstufung | Citigroup | Sell → Neutral |
| 2017-12-13 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-11-30 | Eingeleitet | Lake Street | Buy |
| 2016-12-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-12-22 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2015-11-12 | Eingeleitet | Citigroup | Sell |
| 2015-05-01 | Bestätigt | Dougherty & Company | Buy |
| 2015-01-12 | Eingeleitet | Northland Capital | Outperform |
| 2014-01-31 | Bestätigt | Dougherty & Company | Buy |
| 2014-01-29 | Bestätigt | Brean Capital | Buy |
| 2013-11-11 | Bestätigt | Dougherty & Company | Buy |
| 2013-08-29 | Bestätigt | Dougherty & Company | Buy |
| 2011-09-20 | Bestätigt | Ticonderoga | Buy |
| 2010-02-08 | Hochstufung | Jefferies & Co | Hold → Buy |
| 2009-12-09 | Hochstufung | UBS | Sell → Neutral |
| 2009-03-09 | Herabstufung | Soleil | Buy → Hold |
| 2009-01-30 | Hochstufung | Piper Jaffray | Neutral → Buy |
| 2008-12-22 | Bestätigt | Jefferies & Co | Hold |
| 2008-08-20 | Bestätigt | Jefferies & Co | Hold |
Alle ansehen
Accuray Inc Aktie (ARAY) Neueste Nachrichten
Accuray Fiscal Q4 Swings to Loss, Revenue Falls - Moomoo
ARAY|Accuray Inc|Price:0.295|Chg%:-0.020 - TradingKey
Accuray Inc (ARAY) (Q4 2026) Earnings Call Highlights: Strategic - GuruFocus
ARAY Looks 77.3% Undervalued on GF Value™ Despite Financial Chal - GuruFocus
Accuray Incorporated Q4 2026 Earnings Call Summary - Yahoo Finance
Accuray earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Aug 19 (Reuters)Accuray Incorporated Q4 Ne - Moomoo
Accuray (ARAY) Telefonkonferenz zu den Ergebnissen des 4. Quartals des Geschäftsjahres 2026: Servicewachstum, Rückgang der Produktumsätze - TradingKey
Earnings call transcript: Accuray posts mixed Q4 2026 results as revenue slips - Investing.com
Accuray Q4 2026 Earnings Call: Complete Transcript - Benzinga
Accuray Incorporated reports results for the quarter ended June 30Earnings Summary - TradingView
Is Accuray Inc (ARAY) a Value Trap After Q4 Earnings Miss? EPS - GuruFocus
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results - Investing News Network
Accuray Q4 Results: EPS beats estimate, sales miss by 4.16% - scanx.trade
ARAY Looks 78.0% Undervalued on GF Value™ but Faces Profitabilit - GuruFocus
ARAY Looks 78.0% Undervalued on GF Value™ - GuruFocus
Accuray: Fiscal Q4 Earnings Snapshot - marketscreener.com
Accuray posts narrower-than-feared Q4 loss as cost cuts exceed targets - Investing.com Canada
Accuray Q4 FY2026 Earnings: Margin Expands Despite Product Revenue Decline - TradingKey
Accuray Reports $100.9 Million Fourth-Quarter Revenue and $1.9 Million Net Loss - Quiver Quantitative
BRIEF-Accuray Incorporated Q4 Revenue USD 100.919 Million - TradingView
Accuray Incorporated Reports Earnings Results for the Fourth Quarter Ended June 30, 2026 - marketscreener.com
Accuray Q4 FY26 slides: service gains offset product revenue drop By Investing.com - Investing.com Canada
Accuray (ARAY) Trading Summary: Falls 3.55% to $0.32 for the Current Session; Session Range View: Support at $0.30 and Resistance at $0.34 Frame the Range in the Available RecordHidden Order - Vinanet
ARAY Looks 76.5% Undervalued on GF Value™ - GuruFocus
Accuray Incorporated expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Earnings Preview: Accuray to Report Financial Results Post-market on August 19 - Moomoo
Accuray Inc (ARAY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments - TradingView
Accuray names two executives to lead transformation efforts By Investing.com - Investing.com Canada
Accuray (NASDAQ: ARAY) seeks approval for $55M recapitalization, dilution and reverse split - Stock Titan
Accuray | PRE 14A: Preliminary proxy statements relating to merger or acquisition - Moomoo
Accuray Incorporated Announces Executive Appointments - marketscreener.com
Accuray Inc (ARAY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Neuberger Berman Group LLC Trims Accuray Inc (ARAY) Stake -- Sha - GuruFocus
Primer: Accuray Inc (ARAY US)Aug 2026 - Smartkarma
Accuray Transfers Listing to Nasdaq Capital Market - The Globe and Mail
Accuray Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Radiation therapy company Accuray will discuss results Aug. 19 - Stock Titan
Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026 - marketscreener.com
Neuberger Berman Group (ARAY) discloses 5.48M Accuray shares in 13G/A filing - Stock Titan
Accuray | SCHEDULE 13G/A: Others - Moomoo
Accuray Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Form S-3 Accuray Incorporated For: 31 July By Investing.com - Investing.com Nigeria
Accuray Inc (ARAY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Accuray swaps $40M debt for equity, raises $15M cash from TCW - scanx.trade
Beverly Huss and Anne LeGrand resign from Accuray board - TradingView
Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation - PR Newswire
Accuray Inc (ARAY) Institutional Confidence - TradingKey
Accuray Incorporated announced that it expects to receive $15 million in funding - marketscreener.com
Accuray Inc (ARAY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Finanzdaten der Accuray Inc-Aktie (ARAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Accuray Inc-Aktie (ARAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Peralta Leonel | SVP, Chief Operations Officer |
Feb 28 '26 |
Option Exercise |
0.00 |
83,723 |
0 |
83,723 |
| MAYER STEVEN F | Director |
Feb 20 '26 |
Buy |
0.56 |
54,875 |
30,878 |
1,545,620 |
| MAYER STEVEN F | Director |
Feb 18 '26 |
Buy |
0.53 |
126,125 |
67,199 |
1,421,745 |
| MAYER STEVEN F | Director |
Feb 19 '26 |
Buy |
0.53 |
69,000 |
36,598 |
1,490,745 |
| Scott Byron C | Director |
Dec 31 '25 |
Option Exercise |
0.00 |
9,433 |
0 |
162,727 |
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):